ELAVL1 and nasopharyngeal carcinoma: In NPC, LINC00324 activates the PI3K/AKT pathway to inhibit apoptosis and autophagy by interacting with miR-3164 and recruiting HuR protein to upregulate PAD4 expression, thereby promoting NPC malignancy (12).